GenoMed, Inc.

GenoMed, Inc. uses medical genomics and biotechnology to develop disease management solutions, including drug discovery and preventive molecular medicine. The company provides genomics-based disease management services, develops new drugs, and repurposes existing drugs for new disease indications. It offers a Clinical Outcomes Improvement Program for patients with conditions such as hypertension, type 2 diabetes, and emphysema, and conducts research in preventive molecular medicine to identify disease genes and apply proprietary treatments. The company collaborates with pharmaceutical companies for drug discovery and development, and develops products and techniques for women's health, including microbicidal gels and software for 3D ultrasound reconstruction, fetal growth monitoring, and risk assessment. Advisory services are provided to support the adoption of genomics-based preventive medicine. The company serves research-oriented pharmaceutical companies, healthcare providers, physician groups, and patients with common diseases. The company was founded in 2001 and is based in Leesburg, Florida.